OctoNerv LLC has announced the completion of a functional electronic prototype for an implantable breast reconstruction device, marking a milestone in its ongoing research and development efforts.
The prototype is being explored as a potential approach to addressing unmet needs in post-mastectomy breast reconstruction, particularly by enabling controlled anatomical projection as part of reconstructive outcomes.
Designed for feasibility evaluation rather than clinical use, the system combines a soft silicone structure with internal micro-actuation, pressure-sensing capabilities, wireless charging, and Bluetooth Low Energy connectivity. These features allow researchers to assess the mechanical and electronic performance of the concept in a controlled, non-clinical setting.
The company emphasized that the device remains firmly in the research stage. It is not a commercial product, has not undergone clinical validation, and has not been tested in animals or humans. Development of the prototype was undertaken solely to support early-stage feasibility studies and informed discussions with experts.
OctoNerv’s current activities are focused on research and development, gathering expert feedback, and engaging with clinical professionals, innovation programs, and research institutions. These efforts are intended to guide responsible future development and to evaluate whether the technology may eventually have translational relevance in reconstructive healthcare.
Founded as an early-stage medical technology company, OctoNerv LLC is privately held and headquartered in Allentown, Pennsylvania. The company specializes in the exploration of innovative electronic implant concepts for reconstructive and restorative medical applications, with its current research initiative centered on electronic implant systems for breast reconstruction.
